Retraction

The Use of Cytotoxic Drugs as First Line Chemotherapy for EGFR (+) Nonsquamous NSCLC: A Network Meta-Analysis

Paper Information

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1155/2023/9841863
Additional Notes:

See also: https://pubpeer.com/publications/50E49A1CD43E6FCDE939EBD58DB129

Citations (4)

4
Total Citations
1
Post-Retraction
(25.0%)
1
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
0 After 2+ years
295 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
In silico Molecular Docking, Molecular Dynamic Simulation and ADME Study of New (2-Methyl Benzimidazole-1-yl)-N- Derivatives with Potential Anti-proliferative Activity
Mariam Saeb, Monther Faisal Mahdi, Foad A. Al-saady
Turkish computational and theoretical chemistry/Turkish computational and theoretical chemistry : Open Access
Published: Sep 2024
295 days after retraction
Retracted: The Use of Cytotoxic Drugs as First Line Chemotherapy for EGFR (+) Nonsquamous NSCLC: A Network Meta-Analysis
Disease Markers
Disease Markers Open Access
Published: Nov 2023
Same day as retraction
In silico evaluation of binding interaction and ADME study of new 1,3-diazetidin-2-one derivatives with high antiproliferative activity
FarahHaidar Abdulredha, MontherFaisal Mahdi, Ayad Kareem Khan
Journal of Advanced Pharmaceutical Technology amp Research Open Access
Published: Jul 2023
6 citations
151 days before retraction
Quick Stats
Total Citations: 6
Years Since Retraction: 2.0 year
Open Access: Yes
Last Checked: Jul 24, 2025